FDA application withdrawn to market Viramune for new use.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000635:transmission*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D014481:United States; D014486:United States Food and Drug Administration
D019829:Nevirapine